AU2016219676A1 - Anti-activin A antibodies and uses thereof - Google Patents
Anti-activin A antibodies and uses thereofInfo
- Publication number
- AU2016219676A1 AU2016219676A1 AU2016219676A AU2016219676A AU2016219676A1 AU 2016219676 A1 AU2016219676 A1 AU 2016219676A1 AU 2016219676 A AU2016219676 A AU 2016219676A AU 2016219676 A AU2016219676 A AU 2016219676A AU 2016219676 A1 AU2016219676 A1 AU 2016219676A1
- Authority
- AU
- Australia
- Prior art keywords
- antibodies
- activin
- derivatives
- polypeptides
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Abstract
Abstract The disclosure provides compositions and methods relating to or derived from anti activin A binding proteins, including antibodies. In particular embodiments, the disclosure provides fully human, humanized, and chimeric anti-activin A antibodies that bind human activin A, activin A-binding fragments and derivatives of such antibodies, and activin A-binding polypeptides comprising such fragments. Other embodiments provide nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having activin A related disorders or conditions including cachexia related to gonadal cancer, other cancers, rheumatoid arthritis, and other diseases.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2016219676A AU2016219676A1 (en) | 2006-09-08 | 2016-08-25 | Anti-activin A antibodies and uses thereof |
| AU2018201242A AU2018201242B2 (en) | 2006-09-08 | 2018-02-21 | Anti-activin A antibodies and uses thereof |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60/843,430 | 2006-09-08 | ||
| US60/956,653 | 2007-08-17 | ||
| AU2012265564A AU2012265564B2 (en) | 2006-09-08 | 2012-12-18 | Anti-activin A antibodies and uses thereof |
| AU2016219676A AU2016219676A1 (en) | 2006-09-08 | 2016-08-25 | Anti-activin A antibodies and uses thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2012265564A Division AU2012265564B2 (en) | 2006-09-08 | 2012-12-18 | Anti-activin A antibodies and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2018201242A Division AU2018201242B2 (en) | 2006-09-08 | 2018-02-21 | Anti-activin A antibodies and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2016219676A1 true AU2016219676A1 (en) | 2016-09-15 |
Family
ID=56898953
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2016219676A Abandoned AU2016219676A1 (en) | 2006-09-08 | 2016-08-25 | Anti-activin A antibodies and uses thereof |
| AU2018201242A Active AU2018201242B2 (en) | 2006-09-08 | 2018-02-21 | Anti-activin A antibodies and uses thereof |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2018201242A Active AU2018201242B2 (en) | 2006-09-08 | 2018-02-21 | Anti-activin A antibodies and uses thereof |
Country Status (1)
| Country | Link |
|---|---|
| AU (2) | AU2016219676A1 (en) |
-
2016
- 2016-08-25 AU AU2016219676A patent/AU2016219676A1/en not_active Abandoned
-
2018
- 2018-02-21 AU AU2018201242A patent/AU2018201242B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018201242A1 (en) | 2018-03-15 |
| AU2018201242B2 (en) | 2019-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009002571A (en) | Anti-activin a antibodies and uses thereof. | |
| MX2009013824A (en) | Antigen binding proteins that bind par-2. | |
| MX2007006921A (en) | Compositions and methods relating to anti igf-1 receptor antibodies. | |
| MX2008009886A (en) | Antibodies that bind par-2. | |
| PH12017501025A1 (en) | Antigen binding proteins capable of binding thymic stromal lymphopoietin | |
| WO2008108986A3 (en) | Methods and compositions for treating tumor diseases | |
| TN2012000268A1 (en) | Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof | |
| WO2004013180A3 (en) | Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof | |
| WO2006089230A3 (en) | Human monoclonal antibodies to prostate specific membrane antigen (psma) | |
| MY162624A (en) | Antibodies directed to her-3 and uses thereof | |
| WO2007067991A3 (en) | Human monoclonal antibodies to o8e | |
| WO2008063771A3 (en) | Anti-cd20 antibodies and methods of use | |
| EP3670534A3 (en) | Human fgf receptor and beta-klotho binding proteins | |
| EP2352523A4 (en) | Improved anti-cd19 antibodies | |
| WO2008017963A3 (en) | Antigen binding molecules that bind egfr, vectors encoding same, and uses thereof | |
| WO2013192596A3 (en) | Antigen binding proteins that bind ccr2 | |
| WO2008136848A3 (en) | Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease | |
| WO2006068975A3 (en) | Binding proteins specific for human matriptase | |
| WO2008151819A3 (en) | Treatment of tumors using specific anti-l1 antibody | |
| WO2007075915A3 (en) | Monoclonal antibodies against orthopoxviruses | |
| WO2016028523A3 (en) | Antigen binding proteins that bind cxcr3 | |
| WO2013191982A3 (en) | Antigen binding proteins that bind igf1r | |
| AU2016219676A1 (en) | Anti-activin A antibodies and uses thereof | |
| WO2006091326A8 (en) | Anti-prl-3 antibodies and methods of use thereof | |
| JO3379B1 (en) | Human antigen binding proteins that bind b-klotho, fgf receptors and complexes thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |